270 related articles for article (PubMed ID: 34216725)
1. Intestinal multicellular organoids to study colorectal cancer.
Idris M; Alves MM; Hofstra RMW; Mahe MM; Melotte V
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188586. PubMed ID: 34216725
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
Li J; Liu J; Xia W; Yang H; Sha W; Chen H
Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
[TBL] [Abstract][Full Text] [Related]
3. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line.
Pyo DH; Hong HK; Lee WY; Cho YB
Cancer Biol Ther; 2020 Jun; 21(6):495-502. PubMed ID: 32208894
[TBL] [Abstract][Full Text] [Related]
4. The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer.
Subtil B; Cambi A; Tauriello DVF; de Vries IJM
Front Immunol; 2021; 12():724883. PubMed ID: 34691029
[TBL] [Abstract][Full Text] [Related]
5. Intestinal organoids: a model to study the role of microbiota in the colonic tumor microenvironment.
Nalluri H; Subramanian S; Staley C
Future Microbiol; 2020 Oct; 15():1583-1594. PubMed ID: 33215543
[TBL] [Abstract][Full Text] [Related]
6. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
7. Intestinal organoids: A versatile platform for modeling gastrointestinal diseases and monitoring epigenetic alterations.
Ghorbaninejad M; Asadzadeh-Aghdaei H; Baharvand H; Meyfour A
Life Sci; 2023 Apr; 319():121506. PubMed ID: 36858311
[TBL] [Abstract][Full Text] [Related]
8. Organoids Are Limited in Modeling the Colon Adenoma-Carcinoma Sequence.
Tokumaru Y; Oshi M; Patel A; Tian W; Yan L; Matsuhashi N; Futamura M; Yoshida K; Takabe K
Cells; 2021 Feb; 10(3):. PubMed ID: 33668713
[TBL] [Abstract][Full Text] [Related]
9. Hydrogel-based colorectal cancer organoid co-culture models.
Luo X; Fong ELS; Zhu C; Lin QXX; Xiong M; Li A; Li T; Benoukraf T; Yu H; Liu S
Acta Biomater; 2021 Sep; 132():461-472. PubMed ID: 33388439
[TBL] [Abstract][Full Text] [Related]
10. Advances in Modeling the Immune Microenvironment of Colorectal Cancer.
Yoon PS; Del Piccolo N; Shirure VS; Peng Y; Kirane A; Canter RJ; Fields RC; George SC; Gholami S
Front Immunol; 2020; 11():614300. PubMed ID: 33643296
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
12. Emerging Prospects for the Study of Colorectal Cancer Stem Cells using Patient-derived Organoids.
Ding L; Yang Y; Lu Q; Cao Z; Weygant N
Curr Cancer Drug Targets; 2022; 22(3):195-208. PubMed ID: 35078398
[TBL] [Abstract][Full Text] [Related]
13. Tumor organoid model of colorectal cancer (Review).
Yang C; Xiao W; Wang R; Hu Y; Yi K; Sun X; Wang G; Xu X
Oncol Lett; 2023 Aug; 26(2):328. PubMed ID: 37415635
[TBL] [Abstract][Full Text] [Related]
14. Engineered materials to model human intestinal development and cancer using organoids.
Cruz-Acuña R; García AJ
Exp Cell Res; 2019 Apr; 377(1-2):109-114. PubMed ID: 30794801
[TBL] [Abstract][Full Text] [Related]
15. Organoids and Colorectal Cancer.
Barbáchano A; Fernández-Barral A; Bustamante-Madrid P; Prieto I; Rodríguez-Salas N; Larriba MJ; Muñoz A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071313
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids.
Subtil B; Iyer KK; Poel D; Bakkerus L; Gorris MAJ; Escalona JC; van den Dries K; Cambi A; Verheul HMW; de Vries IJM; Tauriello DVF
Front Immunol; 2023; 14():1105244. PubMed ID: 36761758
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
[TBL] [Abstract][Full Text] [Related]
18. Specific Labeling of Stem Cell Activity in Human Colorectal Organoids Using an ASCL2-Responsive Minigene.
Oost KC; van Voorthuijsen L; Fumagalli A; Lindeboom RGH; Sprangers J; Omerzu M; Rodriguez-Colman MJ; Heinz MC; Verlaan-Klink I; Maurice MM; Burgering BMT; van Rheenen J; Vermeulen M; Snippert HJG
Cell Rep; 2018 Feb; 22(6):1600-1614. PubMed ID: 29425513
[TBL] [Abstract][Full Text] [Related]
19. Organoid Models of Tumor Immunology.
Yuki K; Cheng N; Nakano M; Kuo CJ
Trends Immunol; 2020 Aug; 41(8):652-664. PubMed ID: 32654925
[TBL] [Abstract][Full Text] [Related]
20. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
